Temephos is an organophosphate larvicide used worldwide to kill mosquito larvae in water containers, cisterns, and other standing-water habitats where disease-carrying species breed. The World Health Organization classifies it as Class III, meaning “slightly dangerous,” and has long recommended it for treating drinking-water sources at approved doses. That classification puts it among the least acutely toxic organophosphates, but the safety picture is more layered than a single WHO rating suggests, especially when you look at what animal studies, environmental persistence data, and community practices reveal.
How Temephos Kills Mosquito Larvae
Temephos belongs to the organophosphate family of pesticides, all of which share the same basic trick: they block an enzyme called acetylcholinesterase. That enzyme’s job is to break down a chemical messenger in the nervous system after it has done its work. When the enzyme is blocked, the messenger builds up, nerves fire uncontrollably, and the organism dies. In mosquito larvae, this is lethal at very low concentrations.
Compared to more potent organophosphates used in agriculture, temephos is a relatively weak inhibitor of the enzyme in mammalian nervous tissue. The bond it forms with the enzyme is more easily reversed, which is part of the reason it earned its low-toxicity classification for humans and other mammals.
Effectiveness Against Disease-Carrying Mosquitoes
Temephos has been in continuous use for dengue vector control since the 1950s in some countries, and decades of field evidence support its ability to reduce immature mosquito populations. A systematic review of community-level temephos programs found that all eleven studies examining single-intervention use reported reductions in larval and pupal stages compared to untreated controls. How long the treated water stayed larvae-free varied with dosage, season, frequency of reapplication, and the type of water container.
In laboratory and field evaluations, temephos routinely achieves complete kill of target species when populations are susceptible. A 2023 study evaluating a commercial temephos formulation against the Asian tiger mosquito in Malaysia found that after 24 hours of exposure, ten out of sixteen tested populations showed 100 percent larval mortality, confirming that the product remains useful where resistance has not yet developed.
Laboratory trials comparing temephos to a biological larvicide, Bacillus thuringiensis var. israelensis (Bti), found both agents achieved near-total mortality against Anopheles mosquito larvae. In one Ethiopian evaluation, temephos killed 100 percent of larvae from both tested populations, while Bti achieved 99.7 to 100 percent.
The WHO Safety Rating and What It Means for Humans
The WHO’s Class III designation for temephos is based primarily on its acute oral toxicity in rats, which is relatively low for an organophosphate. A comprehensive toxicology review noted that the no-observed-adverse-effect level in rats was 2.3 mg/kg/day over 90 days, based on brain enzyme inhibition. Cholinergic symptoms, the classic signs of organophosphate poisoning like excessive salivation and tremors, appeared in rats only at doses around 100 mg/kg/day. The concentrations used in drinking-water treatment are orders of magnitude below these thresholds, typically around 1 mg per liter.
Clinical studies in humans have not demonstrated clear harmful effects from chronic low-dose exposure through treated water. That said, the absence of detected harm in clinical research is not the same as proof of safety, and the human evidence base is thinner than you might expect for a chemical applied directly to drinking water in dozens of countries.
What Animal Studies Raise Concerns About
While the acute toxicity picture looks manageable, research on longer-term and developmental effects in animals paints a more cautious picture. A study on prenatal exposure in rodents found that animals exposed to temephos during fetal development displayed hyperactivity, repetitive behaviors, and impaired social interaction. The researchers noted that these behavioral changes resemble features of neurodevelopmental conditions and argued the findings should prompt closer scrutiny of temephos use in countries where it is widely applied.
At the molecular level, some research has identified genotoxic effects from temephos exposure, meaning it can damage DNA under certain experimental conditions. A review of the organophosphate’s toxicity profile noted that while clinical studies have not shown clear harm from chronic human consumption, animal models have demonstrated both neurodevelopmental toxicity and genotoxic potential.
These findings do not automatically translate to human risk at the low doses used in water treatment. But they do suggest that the safety profile is not as cut-and-dried as the WHO Class III label might imply, and that populations with high or prolonged exposure deserve ongoing monitoring.
Metabolites and What Happens Inside the Body
When temephos enters a mammalian body, it does not simply pass through or break down into harmless compounds. Research tracking its metabolism in rats identified at least eleven different breakdown products, including several that are biologically active. Among these metabolites are temephos-oxon, a more potent enzyme inhibitor than the parent compound, and bisphenol S, an industrial chemical that has attracted its own body of safety research in recent years.
The presence of reactive metabolites means that the parent compound’s low toxicity does not tell the full story. The body’s own metabolic processes can convert temephos into forms that are more biologically active, not less. Understanding the toxicity of these downstream products is an ongoing area of investigation.
How Temephos Breaks Down in the Environment
Temephos degrades in water through two main routes: hydrolysis, where water molecules break the chemical bonds, and photodegradation, where sunlight does the work. Both processes follow predictable patterns, but neither is fast. In neutral water at around 30°C, the half-life of temephos through hydrolysis alone is roughly 590 hours, or about 25 days. Alkaline conditions speed this up considerably, cutting the half-life to around 125 hours at pH 11.
Sunlight-driven degradation on its own is similarly slow, with a half-life of about 545 hours in the absence of certain dissolved ions. However, the presence of nitrate ions in water acts as a photosensitizer, dramatically accelerating breakdown and reducing the half-life to roughly 44 hours. This means temephos will persist longest in shaded, acidic, nitrate-poor water, which is exactly the kind of stagnant container water where it is often applied.
Effects on Fish and Other Aquatic Life
Temephos is not selective. It can harm non-target aquatic organisms at concentrations above those used for mosquito control but well within the range that might accumulate in certain environments. A study testing temephos-based formulations on two freshwater fish species found lethal concentrations (LC50) in the range of 5 to 7 mg of active ingredient per liter. Under the Globally Harmonized System for chemical classification, this places temephos-based formulations in the “toxic to aquatic life” category.
Field evaluations in experimental pools in Mexico showed that temephos significantly reduced the diversity of aquatic insect communities. The Shannon diversity index, a common measure of ecosystem richness, was lowest in temephos-treated pools compared to untreated controls and pools treated with the biological agent Bti. Predatory beetles, water bugs, and dragonfly larvae were severely affected. These are the same predatory insects that naturally consume mosquito larvae, so eliminating them can create a counterproductive cycle once the chemical wears off.
The Growing Problem of Resistance
Decades of continuous use have predictably led to resistance in mosquito populations across multiple continents. In Colombia, widespread temephos resistance in the primary dengue vector was found to compromise the national vector control strategy. The resistance appeared to be driven by metabolic mechanisms, particularly increased activity of detoxifying enzymes like cytochrome P450 oxidases, rather than mutations at the target site itself.
Similar patterns have appeared elsewhere. In Brazil, a laboratory strain developed resistance through elevated activity of glutathione S-transferases and esterases. In Greece, the Asian tiger mosquito was found to have amplified specific carboxylesterase genes, with some showing 27-fold increases in expression compared to susceptible populations. Genetic crosses confirmed a strong link between these gene amplifications and survival after temephos exposure.
A study in Laos found moderate resistance in wild populations of the dengue vector, with resistance ratios below five. Even moderate resistance matters operationally, because it means field doses that should be lethal are no longer reliably killing all larvae. Once resistance becomes established in a mosquito population, it can persist for years even after the insecticide is withdrawn, though some studies have documented partial reversion when selection pressure is removed.
How Temephos Compares to Alternative Larvicides
Public health programs increasingly have options beyond temephos, and each comes with trade-offs in effectiveness, environmental impact, and cost.
Bti, a bacterial larvicide, is the most environmentally benign alternative. It had virtually no effect on non-target aquatic insect communities in field trials, and aquatic insect diversity remained nearly as high as in untreated pools. The downside is that Bti provides inconsistent control in many settings and breaks down quickly, requiring frequent reapplication. In one head-to-head trial in Mexico, temephos provided nine consecutive weeks of Anopheles control, while Bti offered little consistent suppression.
Spinosad, derived from a soil bacterium, matched or exceeded temephos in larvicidal power and provided longer-lasting control of some mosquito species. But its ecological footprint was similar to temephos: it severely reduced populations of predatory aquatic insects, with intermediate diversity scores between temephos and untreated pools.
Insect growth regulators like pyriproxyfen work through a completely different mechanism, disrupting mosquito development rather than attacking the nervous system. A comparative trial in Pakistan found pyriproxyfen provided significantly better control than temephos against all three tested mosquito species, and its different mode of action means it remains effective against temephos-resistant populations. A semi-field trial in Laos confirmed that pyriproxyfen maintained activity above the WHO’s acceptable threshold for at least 28 weeks.
The practical calculus for vector control programs often comes down to cost, local resistance profiles, and whether the treated water is used for drinking. Temephos remains cheap and widely available, which keeps it in service even where alternatives might perform better.
Community Perception and Practical Challenges
How people actually use and react to temephos matters as much as its laboratory profile. A large study from the Camino Verde trial in Mexico found significant gaps in coverage: roughly 42 percent of rural and 21 percent of urban households had received no temephos program visit in the previous year. Among households that were visited, fieldworkers observed the chemical actually present in a water container in only about 21 percent of cases.
Public attitudes toward the chemical are mixed. In that same Mexican study, about three-quarters of households did not believe bathing with temephos-treated water carried health risks, but roughly half believed drinking or cooking with it could be harmful, and almost 18 percent were unsure. These beliefs can lead people to remove temephos from their water containers after health workers leave, or to refuse the treatment altogether.
Practical sensory issues compound the trust problem. A field evaluation in Ethiopia noted that temephos turned treated water whitish and produced a strong odor that made communities wary of using the treated habitats. When people can see and smell a chemical in their water, reassurances about safety face an uphill battle regardless of what the toxicology data say.
Occupational Exposure for Mosquito Control Workers
The people most heavily exposed to temephos are not the communities drinking treated water but the workers who mix, carry, and apply the product daily. A cross-sectional study of 43 mosquito control workers in Malaysia found high rates of respiratory symptoms: about a quarter reported difficulty breathing, and nearly a fifth had chronic cough or phlegm production. Lung function testing showed restrictive patterns in 45 percent and obstructive patterns in 25 percent, meaning only 30 percent of workers had normal results. These workers were exposed to multiple pesticides, so temephos cannot be singled out as the sole cause, but the findings highlight that occupational risks from routine larvicide application are real and underappreciated.
Protective equipment use varies widely across vector control programs, especially in lower-income settings where temephos is most heavily used. Workers who mix concentrated formulations without gloves, masks, or adequate ventilation accumulate exposure through skin absorption and inhalation that far exceeds what a household encounters through treated drinking water. The gap between the safety profile established for end users and the actual conditions facing applicators is one of the least discussed aspects of temephos safety.
What Happens When Temephos Meets Chlorine
In many communities, water treated with temephos also undergoes chlorination for disinfection. Research investigating what happens when temephos reacts with sodium hypochlorite, the active ingredient in household bleach and many water treatment systems, has identified oxidized products that differ from the metabolites produced inside living organisms. Among these are compounds where the sulfur bridge in temephos has been oxidized to sulfoxide or sulfone forms, and products where the phosphate groups have been converted from thio- to oxo-forms.
These chlorination byproducts are more water-soluble than the parent compound, meaning they are harder to remove by simple filtration and more likely to remain in treated drinking water. The toxicological significance of these specific byproducts is still being worked out, but the broader concern is straightforward: the chemical that enters your water container is not necessarily the chemical you end up drinking, and the transformation products may have different biological activity than what was originally safety-tested. This is an area where the science is still catching up to real-world practice.